Published in Nat Rev Gastroenterol Hepatol on February 01, 2010
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol Urodyn (2011) 0.84
Distinction between patients with non-erosive reflux disease and functional heartburn. Ann Gastroenterol (2013) 0.79
Alterations in the non-neuronal acetylcholine synthesis and release machinery in esophageal epithelium. Life Sci (2012) 0.76
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22
Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol (2007) 1.79
Management of heartburn not responding to proton pump inhibitors. Gut (2009) 1.75
Functional heartburn: the stimulus, the pain, and the brain. Gut (2002) 1.51
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. Dig Dis Sci (2005) 0.93
Look--but also listen! ReQuest: A new dimension-oriented GERD symptom scale. Drugs Today (Barc) (2004) 0.82
Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86
Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med (2005) 2.35
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol (2009) 1.76
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc (2010) 1.69
Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Am J Gastroenterol (2002) 1.56
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol (2004) 1.52
Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol (2003) 1.50
Bladder cancer presenting as lower-GI bleeding. Dig Dis Sci (2008) 1.47
Prevalence of celiac disease in an adult Jewish population in Israel. Isr Med Assoc J (2010) 1.45
Clinical predictors of Barrett's esophagus length. Gastrointest Endosc (2005) 1.45
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28
Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am (2003) 1.26
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22
The diagnosis of gastroesophageal reflux disease. Am J Med (2010) 1.17
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Laparoscopic resection of a small bowel lipoma with incidental intussusception. JSLS (2011) 1.12
Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res (2004) 1.10
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.07
Pharmacological management of GERD: where does it stand now? Trends Pharmacol Sci (2011) 1.06
Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? Clin Gastroenterol Hepatol (2004) 1.05
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol (2010) 1.04
Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am (2004) 1.04
Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med (2007) 1.03
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci (2008) 0.99
A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2008) 0.99
An algorithm for diagnosis and treatment of refractory GERD. Best Pract Res Clin Gastroenterol (2010) 0.98
Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (N Y) (2010) 0.95
The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol (2005) 0.95
Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol (2006) 0.95
The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol (2008) 0.93
Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol (2014) 0.93
Gastroesophageal reflux disease and sleep disturbances. J Gastroenterol (2012) 0.91
Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol (2006) 0.91
Multiple myeloma presenting with a colonic obstruction and bony lesions: a clinical dilemma. J Clin Oncol (2008) 0.90
Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol (2011) 0.90
Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci (2003) 0.89
Dexlansoprazole MR: a review. Ann Med (2011) 0.88
The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs (2004) 0.88
Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) (2007) 0.87
Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. Clin Cornerstone (2003) 0.86
Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2010) 0.85
Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux. J Clin Gastroenterol (2008) 0.85
Extraesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol (2004) 0.84
Treatment of esophageal motility disorders based on the chicago classification. Curr Treat Options Gastroenterol (2014) 0.84
The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. J Clin Gastroenterol (2012) 0.83
Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep (2006) 0.83
Progression or regression of Barrett's esophagus--is it all in the eye of the beholder? Am J Gastroenterol (2003) 0.83
Power spectral analysis of the sleep electroencephalogram in heartburn patients with or without gastroesophageal reflux disease: a feasibility study. J Clin Gastroenterol (2010) 0.83
Pathogenesis of diarrhea in the adult: diagnostic challenges and life-threatening conditions. Eur J Gastroenterol Hepatol (2006) 0.83
Attitudes and referral patterns of primary care physicians when evaluating subjects with noncardiac chest pain--a national survey. Dig Dis Sci (2005) 0.83
Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res (2013) 0.82
Noncardiac chest pain. Clin Gastroenterol Hepatol (2006) 0.82
Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol (2009) 0.82
Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg (2006) 0.82
Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol (2009) 0.82
Thromboembolic renal infarction due to a renal artery aneurysm in a patient with Ehlers-Danlos syndrome type IV. Eur J Intern Med (2006) 0.81
Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs (2011) 0.81
Ambulatory esophageal pH monitoring: new directions. Dig Dis (2006) 0.81
The effect of restraint stress on the normal colon and on intestinal inflammation in a model of experimental colitis. Dig Dis Sci (2007) 0.81
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol (2002) 0.81
Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information. Am J Gastroenterol (2009) 0.81
Physicians and patients measure different dimension on assessment for gastroesophageal reflux disease-related symptoms [corrected]. J Neurogastroenterol Motil (2011) 0.81
Review: treatment of gastroesophageal reflux disease in the elderly. Am J Med (2010) 0.80
Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci (2002) 0.80
Gastroesophageal reflux disease and sleep. Gastroenterol Clin North Am (2013) 0.80
Functional heartburn. Curr Treat Options Gastroenterol (2005) 0.79
New therapies for non-cardiac chest pain. Curr Gastroenterol Rep (2014) 0.79
A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc (2003) 0.79
The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity. Dig Dis Sci (2009) 0.78
Impaired sleep quality in Crohn's disease depends on disease activity. Dig Dis Sci (2013) 0.78
Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res (2009) 0.78
Current perspectives on the diagnosis and treatment of functional esophageal disorders. Curr Gastroenterol Rep (2003) 0.78
Colon cancer presenting as upper-GI bleeding. Gastrointest Endosc (2006) 0.78
Non-esophageal symptoms cannot differentiate between erosive reflux esophagitis and non-erosive reflux disease in a referred population. Scand J Gastroenterol (2011) 0.77
The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study. J Clin Gastroenterol (2016) 0.77
Assessment of relationship between acid reflux and heartburn using receiver operating characteristic curves. Gastroenterol Clin North Am (2002) 0.77
The role of mucin in GERD and its complications. Nat Rev Gastroenterol Hepatol (2011) 0.77
Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. J Clin Gastroenterol (2016) 0.77
Advancements in the analysis of esophageal pH monitoring in GERD. Nat Rev Gastroenterol Hepatol (2011) 0.77
Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia. Isr Med Assoc J (2003) 0.76
Renal artery stenosis with significant proteinuria may be reversed after nephrectomy or revascularization in patients with the antiphospholipid antibody syndrome: a case series and review of the literature. Rheumatol Int (2010) 0.76
Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies. Ther Apher Dial (2005) 0.76
Noncardiac chest pain: the role of the cardiologist--a national survey. J Clin Gastroenterol (2005) 0.76
CMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature. Platelets (2010) 0.76
Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro. Curr Treat Options Gastroenterol (2007) 0.76
Irritable bowel syndrome: a global view. J Gastroenterol Hepatol (2003) 0.76
Symptom indexes in refractory gastroesophageal reflux disease: overrated or misunderstood? Clin Gastroenterol Hepatol (2011) 0.75
The Overlap Between GERD and Functional Bowel Disorders - When East Meets Rome. J Neurogastroenterol Motil (2010) 0.75
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol (2015) 0.75
Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain. Nat Rev Gastroenterol Hepatol (2011) 0.75
Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. Eur J Gastroenterol Hepatol (2016) 0.75
GERD: Surgery or medical therapy for patients with GERD? Nat Rev Gastroenterol Hepatol (2013) 0.75
Nutcracker esophagus--a nut hard to swallow. J Clin Gastroenterol (2006) 0.75